Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Turnak

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|February 24, 2001
Assumed versus approved breakpointsD A Preston, M R Turnak
Journal of Chemotherapy (Florence, Italy)|August 19, 2000
Assessment of the susceptibility of Streptococcus pneumoniae to cefaclor and loracarbef in 13 countriesS I Bandak, M R Turnak, B S Allen, et al.
International Journal of Clinical Practice|February 28, 2001
Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countriesS I Bandak, M R Turnak, B S Allen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 15, 2002
Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13 countriesM R Turnak, S I Bandak, S K Bouchillon, et al.
International Journal of Clinical Practice|February 29, 2000
Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre studyS I Bandak, L D Bolzon, M R Turnak, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 14, 2001
Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countriesS I Bandak, M R Turnak, B S Allen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|February 24, 2001
Assumed versus approved breakpointsD A Preston, M R Turnak
Journal of Chemotherapy (Florence, Italy)|August 19, 2000
Assessment of the susceptibility of Streptococcus pneumoniae to cefaclor and loracarbef in 13 countriesS I Bandak, M R Turnak, B S Allen, et al.
International Journal of Clinical Practice|February 28, 2001
Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countriesS I Bandak, M R Turnak, B S Allen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 15, 2002
Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13 countriesM R Turnak, S I Bandak, S K Bouchillon, et al.
International Journal of Clinical Practice|February 29, 2000
Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre studyS I Bandak, L D Bolzon, M R Turnak, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 14, 2001
Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countriesS I Bandak, M R Turnak, B S Allen, et al.
Pageof 1